|
Volumn 15, Issue SUPPL. 2, 2002, Pages 697-700
|
Septo-optic dysplasia/optic nerve hypoplasia: Data from the National Cooperative Growth Study (NCGS)
|
Author keywords
Growth hormone treatment; NCGS data; Optic nerve hypoplasia; Septo optic dysplasia
|
Indexed keywords
CORTICOTROPIN;
GROWTH HORMONE;
HYPOPHYSIS HORMONE;
THYROID HORMONE;
AGE;
ARTICLE;
BODY HEIGHT;
CHILD;
CLINICAL FEATURE;
COMORBIDITY;
CONTROLLED STUDY;
CORTICOTROPIN DEFICIENCY;
FEMALE;
FOLLOW UP;
GROWTH HORMONE DEFICIENCY;
GROWTH RATE;
HORMONE SUBSTITUTION;
HUMAN;
HYPOPITUITARISM;
HYPOTHYROIDISM;
MALE;
MEDICAL ASSESSMENT;
OPTIC NERVE HYPOPLASIA;
PATIENT REFERRAL;
SEX DIFFERENCE;
SHORT STATURE;
SIDE EFFECT;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
BRAIN;
CONGENITAL MALFORMATION;
DRUG EFFECT;
GROWTH DISORDER;
OPTIC NERVE DISEASE;
PATHOLOGY;
POSTMARKETING SURVEILLANCE;
PRESCHOOL CHILD;
SEXUAL DEVELOPMENT;
SYNDROME;
BODY HEIGHT;
BRAIN;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
GROWTH DISORDERS;
GROWTH HORMONE;
HUMANS;
MALE;
OPTIC NERVE DISEASES;
PITUITARY HORMONES;
PRODUCT SURVEILLANCE, POSTMARKETING;
SEX CHARACTERISTICS;
SYNDROME;
|
EID: 0036296857
PISSN: 0334018X
EISSN: None
Source Type: Journal
DOI: 10.1515/jpem.2002.15.s2.697 Document Type: Article |
Times cited : (12)
|
References (15)
|